Founder-MD Vijay Bankda resigns effective Aug 11, cites succession planning

CEO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

SYNCOMF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.4%Reaction day

₹14.49

prior close

₹14.61

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+0.6% vs market

Pharmaceuticals peers, median of 164sector+0.1%+0.3% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-1.2

15m

-0.8

30m

-2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.4-0.2+0.6+0.1+0.3

Next day

+9.4+0.2+9.2-0.5+9.9

+5.5+0.4+5.1+0.1+5.4

+2.8+0.4+2.4-0.5+3.4

+5.2+0.6+4.6-1.1+6.3

+7.7+0.9+6.7-0.7+8.4

+7.1+0.9+6.2-1.2+8.3

15d

+38.7+0.9+37.8-0.8+39.5

+35.3+2.3+33.0+0.9+34.4

+60.0-1.1+61.1-3.1+63.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Vijay Shankarlal Bankda, Founder, Promoter and Managing Director of Syncom Formulations (India) Ltd, has resigned effective close of business on August 11, 2026. His resignation letter, received on August 8, cites planned leadership transition and succession planning, and confirms the exit is voluntary with no disagreement with the Board. The Board has acknowledged his service and praised his leadership. This filing is a revised intimation to BSE and NSE. No successor has been named in this disclosure.

Likely market impact

Major leadership change with founder-MD exiting. No governance red flags cited. Watch for successor announcement and any strategic shift.